Puma Biotechnology Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance
November 2, 2023 4:55 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.18, $0.10 better than the analyst estimate of $0.08. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $57.95 million.
GUIDANCE:
Puma Biotech sees FY2023 revenue of $206-209 million, versus the consensus... More
